Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 05, 2026 For Conversion Of 111000 Warrants Into 111000 Equity Shares Of Face Value Of Rs. 10/-
Shelter Pharma's Board approved the allotment of 111,000 equity shares to warrant holders at Rs. 42.25 per share, converting existing warrants. This increases the company's paid-up equity share capital by 0.66%.
May 05 2026 20:05:00
Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, May 01, 2026.
Shelter Pharma has allotted 114,000 equity shares on May 1, 2026, following the conversion of previously issued warrants by non-promoter warrant holders. This increases the company's paid-up equity share capital to Rs. 16.72 crore.
May 01 2026 12:05:00
Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Shelter Pharma secured an order worth $144,000 from Taha Drugs & Chemicals Co. Ltd for Joemega Capsule and All Vitamins tablet. The order is from an international entity in Sudan and will be executed within two months.
Apr 29 2026 12:04:00
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Update On Export Operation
Shelter Pharma commenced dispatch of products for export to Sudan, including its 'Allvitamin' multivitamin supplement. This initiative expands its regular export supply to African markets, contributing to revenue diversification and strengthening global presence.
Apr 16 2026 12:04:00
Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Hired Senior Management Personnel In Line With Business Expansion Plans
Shelter Pharma Limited appointed key senior management personnel, including a Zonal Sales Manager, Regional Sales Manager, sales officers, and an Export Executive. This strategic move aims to strengthen the company's sales hierarchy, improve operational efficiency, and expand market presence both domestically and internationally.
Apr 15 2026 13:04:00
Read More